Motley Fool Extract .. explosive ASX shares that could go parabolic

These shares could be destined for big things in the future.

Posted by

James Mickleboro❯

Published June 25, 6:33 am AEST

Telix Pharmaceuticals Ltd (ASX: TLX)

Another ASX share that could be destined for big things is radiopharmaceuticals specialist Telix Pharmaceuticals. It is another name investors would have been thrilled to hold in recent times. In fact, its share price has rocketed 1,800% over the past five years, and there may still be more in the tank.

The company has kicked off FY 2025 with a bang, reporting revenue of $186 million in the first quarter. That was up 62% on the prior year. Leading the charge is its flagship product Illuccix, which generated $151 million in sales for the quarter. This was an increase of 35% year over year. Add in $33 million from its newly acquired RLS Radiopharmacies, and you have one of the fastest-growing companies on the ASX 200 index.

Looking ahead, full year FY 2025 revenue guidance is $770 million to $800 million, underpinned by new market launches and expanding international demand. Telix is also investing aggressively into R&D, with spending expected to rise 20–25% this year — a signal that the company sees continued momentum ahead.

The ASX share's CEO, Dr. Christian Behrenbruch, explained:

The expansion of our commercial portfolio and launches of Illuccix into new international markets provides a foundation to diversify and grow revenue globally, while we continue to deliver on multiple catalysts in our pipeline.

All in all, Telix looks well placed to build on its impressive run in 2025 and beyond.